{"id":5308,"date":"2024-01-05T18:17:22","date_gmt":"2024-01-05T23:17:22","guid":{"rendered":"https:\/\/www.lrmm.com\/en\/e-quipe\/"},"modified":"2025-09-04T11:48:43","modified_gmt":"2025-09-04T15:48:43","slug":"boldeanu-irina","status":"publish","type":"equipe","link":"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina","title":{"rendered":"Boldeanu Irina"},"content":{"rendered":"\n<p>Irina Boldeanu joined our Litigation Law group in 2023.<\/p>\n\n\n\n<p>Recognized the editions of <em>Best Lawyers: Ones to Watch in Canada\u00ae <\/em>since 2024, Irina is a dedicated and results-driven litigation lawyer with a passion for complex civil and commercial disputes, including class actions defence and commercial litigation. She is particularly attuned to the needs of clients in the health, technology, and pharmaceutical sectors.<\/p>\n\n\n\n<p>She brings a distinctive combination of legal acumen and scientific rigour to her practice, holding a Bachelor of Law (LL.B.), a Juris Doctor (J.D.) and a Bachelor of Biomedical Sciences (B.Sc.). With a strong academic foundation in both law and biomedical science, Irina combines legal precision with a deep understanding of science-driven industries.<\/p>\n\n\n\n<p>Irina regularly appears before the Superior Court of Quebec, the Court of Appeal of Quebec, and the Federal Court of Canada, handling matters involving expert testimony, motions for anonymity, procedural challenges, and strategic case planning in high-stakes litigation. She has contributed to major litigation files\u2014including a $93M commercial dispute\u2014and secured early discontinuances in consumer protection class action cases.<\/p>\n\n\n\n<p>With prior experience at a leading law firms, Irina\u2019s practice also includes drafting complex legal documents in intellectual property, life sciences and privacy law. Her scientific research background includes positions at McGill University and the CHUM Hospital, with peer-reviewed publications in fields such as coronary imaging, HIV-related cardiovascular risks, and intellectual property in the pharmaceutical field.<\/p>\n\n\n\n<p>Irina is known for her intellectual curiosity, strategic thinking, and tenacious advocacy in and out of the courtroom. Her clients value her ability to quickly grasp the technical dimensions of a case while delivering strategic litigation advice grounded in commercial realities.<\/p>\n\n\n\n<p><strong>Publications :<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Co-Author of an article entitled \u201cEnforcement of Foreign Judgments \u2013 December 2023\u201d, Kluwer Law International BV, Wolters Kluwer N.V, 2023.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cTrade Secrets \u2013 Canada\u201d, Les Nouvelles &#8211; Journal of the Licensing Executives Society, Volume LVI No. 2, 2021, <a href=\"https:\/\/ssrn.com\/abstract=3832061\">https:\/\/ssrn.com\/abstract=3832061<\/a>.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u00ab&nbsp;Cinq d\u00e9cisions d\u2019int\u00e9r\u00eat en mati\u00e8re de protection de la propri\u00e9t\u00e9 intellectuelle dans le domaine pharmaceutique en 2020 : lorsque les trait\u00e9s commerciaux internationaux s\u2019invitent dans le d\u00e9bat&nbsp;\u00bb, 2021, 33:2 CPI, <a href=\"https:\/\/www.lescpi.ca\/s\/4185\">https:\/\/www.lescpi.ca\/s\/4185<\/a>.<\/li>\n\n\n\n<li>Author of an article entitled \u00ab&nbsp;Les p\u00e9rip\u00e9ties de l\u2019affaire Drouin ou comment de riches \u0153uvres d\u2019int\u00e9r\u00eat national se sont trouv\u00e9s au c\u0153ur d\u2019un litige complexe en mati\u00e8re de propri\u00e9t\u00e9 intellectuelle&nbsp;\u00bb, <em>ROBIC, LLP Publications<\/em>, 2020, <a href=\"https:\/\/www.robic.ca\/publications\/les-peripeties-de-laffaire-drouin-succession-de-cote-drouin-c-pepin\/\">Les p\u00e9rip\u00e9ties de l\u2019affaire Drouin c. P\u00e9pin | Publications<\/a>.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u00ab&nbsp;Les limites d\u2019une ordonnance de type Norwich : l\u2019importation parall\u00e8le, le \u00ab march\u00e9 gris \u00bb et les impacts de la s\u00e9rialisation&nbsp;\u00bb [2020] <em>ROBIC, LLP Publications<\/em>, <a href=\"https:\/\/www.robic.ca\/en\/publications\/the-limitations-of-a-norwich-order-parallel-imports-grey-market-goods-and-the-impacts-of-serialization\/\">The Limitations of a Norwich Order: Parallel Imports, \u201cGrey Market\u201d Goods and the Impacts of Serialization<\/a><\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cPrevalence and Characterization of Subclinical Coronary Atherosclerotic Plaque with CT among Individuals with HIV: Results from the Canadian HIV and Aging Cohort Study\u201d. <em>Radiology<\/em>, 203297. Advance online publication, 2021, <a href=\"https:\/\/doi.org\/10.1148\/radiol.2021203297\">https:\/\/doi.org\/10.1148\/radiol.2021203297<\/a>.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cUpregulated IL-32 Expression and Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis\u201d. <em>Frontiers in Immunology, 12<\/em>(1235), 2021, <a href=\"https:\/\/doi.org\/10.3389\/fimmu.2021.664371\">https:\/\/doi.org\/10.3389\/fimmu.2021.664371<\/a>.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cAssociation of Epicardial Fat with Non-Calcified Coronary Plaque Volume and With Low Attenuation Plaque in People Living with HIV\u201d,&nbsp;<em>AIDS (London, England)<\/em>: August 1, 2021 &#8211; Volume 35 &#8211; Issue 10 &#8211; p 1575-1584, <a href=\"https:\/\/doi.org\/10.1097\/qad.0000000000002911\">https:\/\/doi.org\/10.1097\/qad.0000000000002911<\/a>.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cQuantification of epicardial fat using non-contrast cardiac CT in an HIV population: Reproducibility and association with other body fat indices\u201d, <em>European Journal of Radiology Open, <\/em>8, 100317, 2021, <a href=\"https:\/\/doi.org\/10.1016\/j.ejro.2020.100317\">https:\/\/doi.org\/10.1016\/j.ejro.2020.100317<\/a> &nbsp;<\/li>\n\n\n\n<li>Co-Author of an article entitled \u00ab&nbsp;Perception, intentions et anxi\u00e9t\u00e9 par rapport \u00e0 la sant\u00e9 cardiovasculaire dans la Cohorte canadienne VIH et vieillissement \u2013 Comparaison avec les facteurs de risque cardiovasculaire et les donn\u00e9es de la tomodensitom\u00e9trie cardiaque&nbsp;\u00bb, Soci\u00e9t\u00e9 de radiologie du Qu\u00e9bec (SRQ), congr\u00e8s annuel, Montr\u00e9al, 2019.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u00ab&nbsp;Quantification par tomodensitom\u00e9trie et mesure de l\u2019association avec l\u2019ath\u00e9roscl\u00e9rose coronarienne subclinique&nbsp;\u00bb, Soci\u00e9t\u00e9 de radiologie du Qu\u00e9bec (SRQ), congr\u00e8s annuel, Montr\u00e9al, 2019.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cReproducibility of epicardial fat quantification using non-contrast cardiac CT in an HIV population\u201d (poster), Canadian Association of Radiologists Annual Scientific Meeting, Montreal, April 12, 2019.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cIncidental findings in CT imaging of coronary artery bypass grafts: results from a Canadian multicenter prospective cohort\u201d, <em>BMC Res Notes, 11<\/em>(1), 72. <a href=\"https:\/\/doi.org\/10.1186\/s13104-018-3168-1\">https:\/\/doi.org\/10.1186\/s13104-018-3168-1<\/a>.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cEpicardial Fat is Increased in the HIV Population and Associated to Coronary Artery Plaque Burden\u201d, Radiological Society of North America 2018 Scientific Assembly and Annual Meeting, November 25 &#8211; November 30, 2018, Chicago IL.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cEpicardial fat is increased in the HIV population and associated to coronary plaque burden\u201d,&nbsp; 27th Annual Canadian Conference on HIV\/AIDS Research (CAHR 2018),<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cUnexpected locations of sentinel lymph nodes in endometrial cancer\u201d, <em>Gynecologic Oncology<\/em>, July 2017, <a href=\"https:\/\/doi.org\/10.1016\/j.ygyno.2017.07.125\">https:\/\/doi.org\/10.1016\/j.ygyno.2017.07.125<\/a> .<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cOutcomes of patients with preoperative grade I endometrial cancer and sentinel lymph node mapping\u201d, <em>Gynecologic Oncology, 145<\/em>, 196, June 2017, <a href=\"https:\/\/doi.org\/10.1016\/j.ygyno.2017.03.449\">https:\/\/doi.org\/10.1016\/j.ygyno.2017.03.449<\/a>.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cUnexpected locations of sentinel lymph nodes in endometrial cancer\u201d, <em>Gynecologic Oncology, 145<\/em>, 52-53, June 2017, <a href=\"http:\/\/dx.doi.org\/10.1016\/j.ygyno.2017.03.129\">http:\/\/dx.doi.org\/10.1016\/j.ygyno.2017.03.129<\/a>.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cIn vivo coronary artery plaque assessment with computed tomography angiography: is there an impact of iterative reconstruction on plaque volume and attenuation metrics?\u201d, <em>Acta Radiol, 58<\/em>(6), 660-669, June 2017, <a href=\"https:\/\/doi.org\/10.1177\/0284185116664229\">https:\/\/doi.org\/10.1177\/0284185116664229<\/a>.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u00ab&nbsp;Association de la graisse \u00e9picardique mesur\u00e9e par scanner cardiaque avec la maladie coronarienne chez les patients VIH positifs&nbsp;\u00bb, Journ\u00e9e des \u00e9tudiants SIDA-MI FRQS, 2017, Montr\u00e9al.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u00ab&nbsp;Association de la graisse \u00e9picardique mesur\u00e9e par scanner cardiaque avec la maladie coronarienne chez les patients VIH positifs&nbsp;\u00bb, Soci\u00e9t\u00e9 de Radiologie Qu\u00e9b\u00e9coise, Congr\u00e8s annuel, November 2017, Montr\u00e9al.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cEpicardial fat and its association to coronary artery plaque burden in the HIV population\u201d,&nbsp;8e Journ\u00e9e scientifique du CRCHUM, October 2017, Montr\u00e9al.<\/li>\n\n\n\n<li>Co-Author of an article entitled <em>\u201c<\/em>Pulmonary computed tomography angiography in the diagnosis of acute pulmonary embolism: an assessment of prevalence and use\u201d, Canadian Association of Radiologists Annual Scientific Meeting, April 2017, Montr\u00e9al.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cEpicardial fat quantitative assessment and its relationship to computed tomography markers of coronary artery plaque vulnerability in HIV patients\u201d, The 26th Annual Canadian Conference on HIV\/AIDS Research, April 2017, Montreal.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u00ab&nbsp;Embolie pulmonaire en tomodensitom\u00e9trie : \u00e9tude de pr\u00e9valence et d\u2019utilisation&nbsp;\u00bb, Journ\u00e9e acad\u00e9mique du d\u00e9partement de radiologie, radio-oncologie et m\u00e9decine nucl\u00e9aire de la facult\u00e9 de m\u00e9decine de l\u2019Universit\u00e9 de Montr\u00e9al, February 2017, Universit\u00e9 de Montr\u00e9al.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u00ab&nbsp;\u00c9valuation in vivo de la plaque coronarienne en tomodensitom\u00e9trie \u2013 la reconstruction it\u00e9rative influence-t-elle la mesure du volume et de l\u2019att\u00e9nuation de la plaque?&nbsp;\u00bb, RBIQ (R\u00e9seau de bio-imagerie du Qu\u00e9bec), 8<sup>e<\/sup> Journ\u00e9e scientifique, January 2016, Montr\u00e9al.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cIn vivo coronary artery plaque assessment with computed tomography angiography \u2013 is there an impact of iterative reconstruction on plaque volume and attenuation metrics?\u201d, RSNA Scientific Assembly and Annual Meeting, McCormick Place, December 2015, Chicago, Illinois.<\/li>\n\n\n\n<li>Co-Author of an article entitled \u201cIn vivo coronary artery plaque assessment with computed tomography angiography \u2013 is there an impact of iterative reconstruction on plaque volume and attenuation metrics?\u201d, American Roentgen Ray Society scientific meeting, April 2015, Toronto.<\/li>\n\n\n\n<li>Co-Author of an article entitled <em>\u00ab&nbsp;L&#8217;effet de la reconstruction it\u00e9rative compar\u00e9e \u00e0 la r\u00e9troprojection filtr\u00e9e sur l&#8217;analyse de plaques coronariennes en angiographie coronarienne par tomodensitom\u00e9trie&nbsp;\u00bb,<\/em> Congr\u00e8s des stagiaires du COPSE, January 2015, Universit\u00e9 de Montr\u00e9al.<\/li>\n<\/ul>\n\n\n\n<p><strong>Conferences :<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Presenting author of \u201cSubclinical coronary atherosclerosis among individuals with HIV on antiretroviral therapy \u2013 Baseline results from the Canadian HIV and Aging Cohort Study\u201d, Canadian Cardiovascular Congress Annual Meeting 2019, Montreal, October 24<sup>th<\/sup> \u2013 27<sup>th<\/sup>, 2019.<\/li>\n\n\n\n<li>Presenting author of \u201cSubclinical coronary atherosclerosis among individuals with HIV on anti retroviral therapy\u201d, Canadian Association of Radiologists Annual Scientific Meeting, Montreal, April 12,2019.<\/li>\n\n\n\n<li>Presenting author of \u201cSubclinical coronary atherosclerosis among individuals with HIV on antiretroviral therapy &#8211; Baseline results from the Canadian HIV and Aging Cohort Study\u201d, Journ\u00e9e universitaire du d\u00e9partement de radiologie, radio-oncologie et m\u00e9decine nucl\u00e9aire de la facult\u00e9 de m\u00e9decine de l\u2019Universit\u00e9 de Montr\u00e9al, Universit\u00e9 de Montr\u00e9al, February 21, 2019.<\/li>\n\n\n\n<li>Presenting author of \u201cSubclinical Coronary Atherosclerosis among Individuals with HIV on Antiretroviral Therapy\u201d, Radiological Society of North America 2018 Scientific Assembly and Annual Meeting, November 25 &#8211; November 30, 2018, Chicago IL.<\/li>\n\n\n\n<li>Presenting author of \u201cIncidental findings in CT imaging of coronary artery bypass grafts &#8211; Results from the Canadian PATENCY-CORONARY trial\u201d, Canadian Association of Radiologists Annual Scientific Meeting, 28-30 May 2015, Montreal.<\/li>\n\n\n\n<li>Presenting author of \u201cCoronary artery bypass graft imaging with 256-slice MDCT angiography and iterative reconstruction method: quantitive evaluation of image quality and radiation dose reduction\u201d, Canadian Association of Radiologists Annual Scientific Meeting, 28-30 May 2015, Montreal.<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"345\" src=\"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/Irina_Boldeanu-1-1024x345.png\" alt=\"\" class=\"wp-image-6335\" style=\"width:227px;height:auto\" srcset=\"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/Irina_Boldeanu-1-1024x345.png 1024w, https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/Irina_Boldeanu-1-300x101.png 300w, https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/Irina_Boldeanu-1-768x258.png 768w, https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/Irina_Boldeanu-1-1536x517.png 1536w, https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/Irina_Boldeanu-1-2048x689.png 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p><\/p>\n","protected":false},"author":4,"featured_media":5304,"menu_order":0,"template":"","meta":{"_acf_changed":true},"equipe_cat":[80],"class_list":["post-5308","equipe","type-equipe","status-publish","has-post-thumbnail","hentry","equipe_cat-attorneys"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Boldeanu Irina - Lapointe Rosenstein Marchand Melan\u00e7on<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Boldeanu Irina - Lapointe Rosenstein Marchand Melan\u00e7on\" \/>\n<meta property=\"og:description\" content=\"Irina Boldeanu joined our Litigation Law group in 2023. Recognized the editions of Best Lawyers: Ones to Watch in Canada\u00ae since 2024, Irina is a dedicated and results-driven litigation lawyer with a passion for complex civil and commercial disputes, including class actions defence and commercial litigation. She is particularly attuned to the needs of clients [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina\" \/>\n<meta property=\"og:site_name\" content=\"Lapointe Rosenstein Marchand Melan\u00e7on\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-04T15:48:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"157\" \/>\n\t<meta property=\"og:image:height\" content=\"157\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina\",\"url\":\"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina\",\"name\":\"Boldeanu Irina - Lapointe Rosenstein Marchand Melan\u00e7on\",\"isPartOf\":{\"@id\":\"https:\/\/www.lrmm.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg\",\"datePublished\":\"2024-01-05T23:17:22+00:00\",\"dateModified\":\"2025-09-04T15:48:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina#breadcrumb\"},\"inLanguage\":\"en-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-CA\",\"@id\":\"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina#primaryimage\",\"url\":\"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg\",\"contentUrl\":\"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg\",\"width\":157,\"height\":157},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Welcome\",\"item\":\"https:\/\/www.lrmm.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Team\",\"item\":\"https:\/\/www.lrmm.com\/en\/team\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Boldeanu Irina\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lrmm.com\/en\/#website\",\"url\":\"https:\/\/www.lrmm.com\/en\/\",\"name\":\"Lapointe Rosenstein Marchand Melan\u00e7on\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lrmm.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-CA\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Boldeanu Irina - Lapointe Rosenstein Marchand Melan\u00e7on","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina\/","og_locale":"en_US","og_type":"article","og_title":"Boldeanu Irina - Lapointe Rosenstein Marchand Melan\u00e7on","og_description":"Irina Boldeanu joined our Litigation Law group in 2023. Recognized the editions of Best Lawyers: Ones to Watch in Canada\u00ae since 2024, Irina is a dedicated and results-driven litigation lawyer with a passion for complex civil and commercial disputes, including class actions defence and commercial litigation. She is particularly attuned to the needs of clients [&hellip;]","og_url":"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina","og_site_name":"Lapointe Rosenstein Marchand Melan\u00e7on","article_modified_time":"2025-09-04T15:48:43+00:00","og_image":[{"width":157,"height":157,"url":"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina","url":"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina","name":"Boldeanu Irina - Lapointe Rosenstein Marchand Melan\u00e7on","isPartOf":{"@id":"https:\/\/www.lrmm.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina#primaryimage"},"image":{"@id":"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina#primaryimage"},"thumbnailUrl":"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg","datePublished":"2024-01-05T23:17:22+00:00","dateModified":"2025-09-04T15:48:43+00:00","breadcrumb":{"@id":"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina#breadcrumb"},"inLanguage":"en-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina"]}]},{"@type":"ImageObject","inLanguage":"en-CA","@id":"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina#primaryimage","url":"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg","contentUrl":"https:\/\/www.lrmm.com\/wp-content\/uploads\/2024\/01\/YKP_6109rc-157x157-1.jpg","width":157,"height":157},{"@type":"BreadcrumbList","@id":"https:\/\/www.lrmm.com\/en\/team\/attorneys\/boldeanu-irina#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Welcome","item":"https:\/\/www.lrmm.com\/en\/"},{"@type":"ListItem","position":2,"name":"Team","item":"https:\/\/www.lrmm.com\/en\/team\/"},{"@type":"ListItem","position":3,"name":"Boldeanu Irina"}]},{"@type":"WebSite","@id":"https:\/\/www.lrmm.com\/en\/#website","url":"https:\/\/www.lrmm.com\/en\/","name":"Lapointe Rosenstein Marchand Melan\u00e7on","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lrmm.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-CA"}]}},"_links":{"self":[{"href":"https:\/\/www.lrmm.com\/en\/wp-json\/wp\/v2\/equipe\/5308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lrmm.com\/en\/wp-json\/wp\/v2\/equipe"}],"about":[{"href":"https:\/\/www.lrmm.com\/en\/wp-json\/wp\/v2\/types\/equipe"}],"author":[{"embeddable":true,"href":"https:\/\/www.lrmm.com\/en\/wp-json\/wp\/v2\/users\/4"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lrmm.com\/en\/wp-json\/wp\/v2\/media\/5304"}],"wp:attachment":[{"href":"https:\/\/www.lrmm.com\/en\/wp-json\/wp\/v2\/media?parent=5308"}],"wp:term":[{"taxonomy":"equipe_cat","embeddable":true,"href":"https:\/\/www.lrmm.com\/en\/wp-json\/wp\/v2\/equipe_cat?post=5308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}